Filana Therapeutics, Inc. (FLNA)
0.929
+0.01
(+0.65%)
USD |
NASDAQ |
Aug 28, 16:00
0.9283
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 44.88M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -60.97% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.7055 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.34% |
Profile
| Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX. |
| URL | http://www.cassavasciences.com |
| Investor Relations URL | http://investor.paintrials.com/ |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 29, 2026 (est.) |
| Last Earnings Release | Jul. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 13, 2010 |
Profile
| Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX. |
| URL | http://www.cassavasciences.com |
| Investor Relations URL | http://investor.paintrials.com/ |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 29, 2026 (est.) |
| Last Earnings Release | Jul. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 13, 2010 |